You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Replicate

Showing 1 - 25 of 1,170
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hypertension Trial (CKD-828, D064, D702)

Not yet recruiting
  • Hypertension
  • CKD-828, D064, D702
  • (no location specified)
May 21, 2023

Hypertension Trial (CKD-828, D064, D701)

Not yet recruiting
  • Hypertension
  • CKD-828, D064, D701
  • (no location specified)
Apr 18, 2023

Bioequivalence Trial in Cairo (Test product (T) 25 mg Film Coated Tablets, Reference product (R) 25 mg Film Coated Tablets)

Completed
  • Bioequivalence
  • Test product (T) 25 mg Film Coated Tablets
  • Reference product (R) 25 mg Film Coated Tablets
  • Cairo, Egypt
    Future Research Center (FRC)
Feb 10, 2022

Heathy Participants Trial (Treatment A (BDA MDI HFO), Treatment B (BDA MDI HFA))

Not yet recruiting
  • Heathy Participants
  • Treatment A (BDA MDI HFO)
  • Treatment B (BDA MDI HFA)
  • (no location specified)
Nov 15, 2023

Healthy Volunteers Trial in Daytona Beach, Dallas (Zanubrutinib)

Recruiting
  • Healthy Volunteers
  • Daytona Beach, Florida
  • +1 more
Mar 15, 2023

Healthy Trial in Toronto (Rupatadine)

Active, not recruiting
  • Healthy
  • Toronto, Ontario, Canada
    Pharma Medica Research Inc.
Apr 27, 2022

Healthy Trial in Jeonju (HCP2201, RLD2205, RLD2206)

Not yet recruiting
  • Healthy
  • Jeonju, Jeollabuk-do, Korea, Republic of
    Chonbuk National University Hospital
Feb 10, 2023

Healthy Trial in Cairo (Nirmatrelvir 150 mg + Ritonavir 100 mg (Reference first dose), Nirmatrelvir 150 mg + Ritonavir 100 mg

Recruiting
  • Healthy
  • Nirmatrelvir 150 mg + Ritonavir 100 mg (Reference first dose)
  • +2 more
  • Cairo, Egypt
    Genuine Research Center GRC
Aug 4, 2022

Biological Availability Trial in Hyderabad (Dasatinib ASD 100 mg, Dasatinib 140 MG [Sprycel])

Completed
  • Biological Availability
  • Dasatinib ASD 100 mg
  • Dasatinib 140 MG [Sprycel]
  • Hyderabad, India
    QPS Bioserve India Pvt Limited
Jun 28, 2022

Evaluate Effectiveness of OCA on Hepatic Outcomes in PBC

Completed
  • Primary Biliary Cholangitis
  • Obeticholic Acid 5 MG
  • +2 more
  • San Diego, California
    Intercept Pharmaceuticals, Inc
Jul 30, 2022

Healthy Trial in Jeonju (HCP2202, RLD2202, RLD2203)

Not yet recruiting
  • Healthy
  • Jeonju, Jeollabuk-do, Korea, Republic of
    Chonbuk National University Hospital
Sep 16, 2022

Healthy Trial in Cairo (Vesicare (Solifenacin Succinate 5 mg) & Betmiga (Mirabegron 50 mg) (Reference first dose), Mirfenacin MR

Completed
  • Healthy
  • Vesicare (Solifenacin Succinate 5 mg) & Betmiga (Mirabegron 50 mg) (Reference first dose)
  • +2 more
  • Cairo, Egypt
    Genuine Research Center GRC
Mar 2, 2023

COPD Trial in Glendale (Treatment A: BGF MDI HFO, Treatment B: BGF MDI HFA)

Recruiting
  • Chronic Obstructive Pulmonary Disease
  • Treatment A: BGF MDI HFO
  • Treatment B: BGF MDI HFA
  • Glendale, California
    Research Site
Jan 18, 2023

Healthy Trial in Jeonju (HCP2202, RLD2202, RLD2203)

Not yet recruiting
  • Healthy
  • Jeonju, Jeollabuk-do, Korea, Republic of
    Jeonbuk University Hospital
Sep 16, 2022

Healthy Volunteers Trial in Austin (Sancuso - Part 1, Sancuso - Part 2)

Completed
  • Healthy Volunteers
  • Sancuso - Part 1
  • Sancuso - Part 2
  • Austin, Texas
    PPD Development
Mar 24, 2022

Bioequivalence Trial in Arzo (Riluzole 50 mg Oral Film, Rilutek 50Mg Tablet)

Completed
  • Bioequivalence
  • Riluzole 50 mg Oral Film
  • Rilutek 50Mg Tablet
  • Arzo, Ticino, Switzerland
    CROSS Research SA Phase 1 Unit
Sep 16, 2021

Healthy Volunteers Trial in Tempe (TAK-906)

Withdrawn
  • Healthy Volunteers
  • Tempe, Arizona
    Celerion
Mar 22, 2022

Bioequivalence Trial in Cairo (Test product (T) 40 mg Hard Gelatin Capsules, Reference product (R) 40 mg Hard Gelatin Capsules)

Completed
  • Bioequivalence
  • Test product (T) 40 mg Hard Gelatin Capsules
  • Reference product (R) 40 mg Hard Gelatin Capsules
  • Cairo, Egypt
    Future Research Center (FRC)
Feb 10, 2022

COPD Trial in Brooklyn (Treatment A (BGF MDI HFO with oral activated charcoal), Treatment B (BGF MDI HFA with oral activated

Recruiting
  • Chronic Obstructive Pulmonary Disease
  • Treatment A (BGF MDI HFO with oral activated charcoal)
  • Treatment B (BGF MDI HFA with oral activated charcoal)
  • Brooklyn, Maryland
    Research Site
Aug 11, 2022

Overactive Bladder(OAB) Trial in Seoul (JLP-2002, Comparator)

Completed
  • Overactive Bladder(OAB)
  • Seoul, Korea, Republic of
    Samsung Medical Center
Jun 10, 2021

Hyperlipemia, Mixed Trial in Seoul (administration of UI018, co-administration of UIC201806 and UIC201602)

Active, not recruiting
  • Hyperlipemia, Mixed
  • administration of UI018
  • co-administration of UIC201806 and UIC201602
  • Seoul, Jongno-gu, Korea, Republic of
    Seoul National University Hospital
Dec 20, 2021

Healthy Volunteers Trial in Saint Louis (Tacrolimus)

Completed
  • Healthy Volunteers
  • Saint Louis, Missouri
    BioPharma Services USA
Jun 24, 2021

Healthy Trial in Cairo (Barcimiant, Olumiant (first dose), Olumiant (second dose))

Completed
  • Healthy
  • Cairo, Egypt
    Genuine Research Center GRC
Aug 9, 2021

Arrhythmia Trial in Phoenix (AliveCor Heart Monitor)

Withdrawn
  • Arrhythmia
  • AliveCor Heart Monitor
  • Phoenix, Arizona
    Mayo Clinic Arizona
Jul 10, 2020

Healthy Trial in Cairo (Revemact, Stromectol (first dose), Stromectol (second dose))

Completed
  • Healthy
  • Cairo, Egypt
    Genuine Research Center GRC
Apr 25, 2021